Overview

Phase II Study for Solid Metastatic Tumors

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
1. To induce immunity-mediated tumor response outside the radiation field (abscopal effect) after chemo-radiation of a metastatic site in metastatic breast cancer patients. 2. To monitor the induction of a T cell response. 3. To explore the role of PET scanning to assess tumor responses/abscopal effect.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Treatments:
Albumin-Bound Paclitaxel
Capecitabine
Docetaxel
Paclitaxel